It was intraurethrally administered by mean of sterile catheter during Chemical Biology Phase I embryonic augmentation protocol of the Myrmidon Program.
| Attributes | Values |
|---|---|
| rdfs:label |
|
| rdfs:comment |
|
| dbkwik:halo-fanon/...iPageUsesTemplate | |
| dbkwik:halofanon/p...iPageUsesTemplate | |
| abstract |
|